Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AstraZeneca Takes Five: DTC Study Finds Five Risks Per Ad Is Optimal For Recall

Executive Summary

An AstraZeneca study on consumer communication through direct-to-consumer television advertisements identifies five risks as the optimal number to include in order to ensure consumer recall of safety information

You may also be interested in...



Rx Safety Communication In Face Of Uncertainty, Multiple Risks, To Be Examined By FDA Panel

FDA’s Risk Communication Advisory Committee will delve into research on communicating uncertainty and how individuals perceive risk and seek information when confronted with multiple risks, during a June 29 meeting.

Rx TV Ads To Get FDA Study On How Visual Cues May Distract From Audio Risks

Data collection in an FDA study of how the audio, visual and textual components of a television ad affect a viewer's intake of information and perception of a drug's risks and benefits is expected to begin in May 2008

Rx TV Ads To Get FDA Study On How Visual Cues May Distract From Audio Risks

Data collection in an FDA study of how the audio, visual and textual components of a television ad affect a viewer's intake of information and perception of a drug's risks and benefits is expected to begin in May 2008

Related Content

UsernamePublicRestriction

Register

LL029263

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel